Liothyronine

The dosage of Liothyronine must be highly individualized based on the patient's age, the severity of the hypothyroidism, and the presence of underlying cardiovascular conditions. Healthcare providers typically follow a "start low and go slow" approach.

• Mild Hypothyroidism: The usual starting dose is 25 mcg daily. The dosage may be increased by 12.5 to 25 mcg every 1 to 2 weeks until the desired clinical response is achieved. The standard maintenance dose is 25 mcg to 75 mcg daily.
• Myxedema: The starting dose is usually 5 mcg daily. Because of the severity of the condition, increases are made cautiously, typically 5 to 10 mcg every 1 to 2 weeks. Maintenance doses range from 50 to 100 mcg daily.
• Simple (Non-toxic) Goiter: The starting dose is 5 mcg daily, with increments of 5 to 10 mcg every week or two. The usual maintenance dose is 75 mcg daily.
• TSH Suppression Test: Typically, 75 to 100 mcg is administered daily for 7 days, followed by a radioactive iodine uptake test.

Liothyronine is used in children, but extreme caution is required to ensure normal growth and development. Dosage is usually based on body weight and age.

• Infants and Children: The recommended starting dose is 5 mcg daily. The dose is increased by 5 mcg increments every 3 to 4 days until the desired response is achieved.
• Congenital Hypothyroidism: Rapid restoration of thyroid levels is critical to prevent permanent intellectual disability. However, levothyroxine (T4) is generally the preferred first-line agent for pediatric patients due to more stable blood levels.

Renal Impairment

Specific dosage adjustments for renal impairment are not typically defined in the manufacturer's labeling, as the drug is primarily metabolized by the liver. However, because thyroid hormones affect renal blood flow, patients with severe kidney disease should be monitored closely for changes in thyroid function tests.

Hepatic Impairment

Since the liver is a primary site for thyroid hormone metabolism and the production of binding proteins (like TBG), patients with significant liver disease may require more frequent monitoring of free T3 and TSH levels. Dose adjustments may be necessary if the liver's ability to process the hormone is compromised.

Elderly Patients

Patients over the age of 65 are more sensitive to the effects of Liothyronine, particularly the cardiovascular effects. The starting dose in the elderly is usually very low (5 mcg daily), and increments are made at longer intervals (3 to 4 weeks) to avoid precipitating heart failure or arrhythmias.

• Consistency is Key: Take Liothyronine at the same time every day to maintain steady hormone levels. Most patients take it in the morning.
• Food Interactions: While Liothyronine is better absorbed with food than levothyroxine, it is still best to take it on an empty stomach (30-60 minutes before breakfast) to ensure the most consistent absorption.
• Swallowing: Tablets should be swallowed whole with a full glass of water. If you have difficulty swallowing, discuss alternative formulations with your pharmacist.
• Storage: Store at room temperature (68°F to 77°F or 20°C to 25°C) in a tight, light-resistant container. Keep away from excessive moisture.

If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up, as this can lead to symptoms of hyperthyroidism (overactive thyroid).

An overdose of Liothyronine results in a hypermetabolic state (thyrotoxicosis). Symptoms include a rapid or irregular heartbeat, chest pain, extreme nervousness, confusion, seizures, and high body temperature. In the event of a suspected overdose, contact emergency services or a poison control center immediately. Treatment usually involves supportive care and medications like beta-blockers to control heart rate and blood pressure.

> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or switch brands without medical guidance, as different formulations may not be bioequivalent.

Side effects of Liothyronine are generally related to the dose being too high, effectively causing symptoms of hyperthyroidism (an overactive thyroid). Common side effects include:

• Nervousness and Anxiety: Feeling "jittery," restless, or having difficulty sitting still.
• Insomnia: Difficulty falling asleep or staying asleep due to increased metabolic stimulation.
• Tachycardia: A rapid or racing heartbeat that you can feel in your chest (palpitations).
• Heat Intolerance: Feeling excessively warm when others are comfortable, often accompanied by increased sweating.
• Tremors: Small, involuntary shaking movements, most commonly in the hands.

• Weight Loss: Unintended weight loss despite a normal or increased appetite.
• Diarrhea: Increased frequency of bowel movements or loose stools due to accelerated gastrointestinal motility.
• Headache: Persistent or tension-type headaches.
• Menstrual Irregularities: Changes in the timing or flow of menstrual periods in women.
• Muscle Weakness: A feeling of fatigue or lack of strength in the muscles, particularly the thighs and upper arms.

• Hair Loss: Temporary hair thinning may occur during the first few months of therapy, particularly in children (this usually resolves as the body adjusts).
• Allergic Reactions: Rash, hives, or itching. These are rare as the drug mimics a natural hormone, but can occur due to inactive ingredients in the tablet.
• Pseudotumor Cerebri: Increased pressure inside the skull, which can cause vision changes and severe headaches (primarily reported in children).

> Warning: Stop taking Liothyronine and call your doctor immediately if you experience any of the following symptoms. These may indicate a life-threatening cardiovascular event or severe thyrotoxicosis.

• Chest Pain (Angina): Pressure, tightness, or pain in the chest, which may spread to the arms, neck, or jaw.
• Shortness of Breath: Difficulty breathing, especially when lying down or during mild exertion.
• Severe Palpitations: A feeling that the heart is skipping beats or beating dangerously fast (arrhythmia).
• Swelling (Edema): New or worsening swelling in the ankles, feet, or legs.
• Fainting or Syncope: Sudden loss of consciousness or feeling like you are about to pass out.
• Seizures: Involuntary muscle contractions or loss of awareness.

• Bone Mineral Density Loss: Chronic over-replacement with thyroid hormones can lead to increased bone resorption, potentially resulting in osteoporosis and an increased risk of bone fractures.
• Cardiac Hypertrophy: Long-term exposure to high levels of T3 can cause the heart muscle to thicken, increasing the risk of heart failure over time.
• Atrial Fibrillation: Especially in elderly patients, long-term use of slightly high doses can trigger chronic heart rhythm disturbances.

FDA BLACK BOX WARNING: NOT FOR TREATMENT OF OBESITY OR WEIGHT LOSS

Thyroid hormones, including Liothyronine, either alone or with other therapeutic agents, should not be used for the treatment of obesity or for weight loss. In euthyroid patients (patients with normal thyroid function), doses within the range of daily hormonal requirements are ineffective for weight reduction. Larger doses may produce serious or even life-threatening manifestations of toxicity, particularly when given in association with sympathomimetic amines such as those used for their anorectic (appetite suppressant) effects. Using Liothyronine specifically for weight loss is dangerous and medically inappropriate.

Report any unusual symptoms or persistent side effects to your healthcare provider. Regular blood tests (TSH and T3 levels) are the best way to ensure your dose is correct and to minimize side effects.

Liothyronine is a potent medication that significantly alters the body's metabolic state. It should only be used under the strict supervision of a healthcare provider. Patients must be aware that thyroid replacement therapy is usually lifelong, and consistency in medication use and laboratory monitoring is essential for safety.

Full Text Summary: The FDA has issued a Black Box Warning stating that Liothyronine must not be used for the treatment of obesity or weight loss. In individuals with normal thyroid function, standard doses are ineffective for weight loss, while high doses can cause severe, life-threatening toxicity, especially if combined with diet pills or stimulants.

• Cardiovascular Risk: Liothyronine increases heart rate and the force of heart contractions. It must be used with extreme caution in patients with cardiovascular disorders, such as coronary artery disease (angina), hypertension, or a history of heart attack. If chest pain or other cardiac symptoms develop, the dose must be reduced or withheld.
• Adrenal Insufficiency: In patients with concomitant (co-existing) adrenal insufficiency, thyroid hormone therapy must not be started until the adrenal condition is treated with glucocorticoids. Starting thyroid hormone first can precipitate an acute adrenal crisis, which is a medical emergency.
• Diabetes Mellitus: Liothyronine can increase blood sugar levels. Patients with diabetes may require an increase in their insulin or oral glucose-lowering medications when starting or changing the dose of Liothyronine.
• Myxedema Coma: While IV Liothyronine is used for this condition, it must be administered with caution as it can cause rapid shifts in fluid and electrolytes, potentially stressing the heart.
• Bone Density: Excessive doses can lead to bone thinning (osteoporosis). Postmenopausal women and those at risk for bone loss should have their TSH levels monitored closely to ensure they are not being over-replaced.

To ensure the safety and efficacy of Liothyronine, your doctor will order regular blood tests:

• TSH (Thyroid Stimulating Hormone): The primary marker used to determine if the dose is correct. High TSH usually means the dose is too low; low TSH usually means the dose is too high.
• Free T3 (Triiodothyronine): Directly measures the amount of active hormone in the blood. This is particularly important for Liothyronine therapy.
• Clinical Evaluation: Regular checks of heart rate, blood pressure, and body weight.
• Bone Density Scans: May be recommended for patients on long-term therapy who are at risk for osteoporosis.

Liothyronine generally does not affect the ability to drive or operate machinery. However, if you experience side effects such as tremors, nervousness, or vision changes (rare), you should avoid these activities until the symptoms resolve.

There is no direct interaction between alcohol and Liothyronine. However, alcohol can worsen certain side effects like rapid heart rate or sleep disturbances. It is best to consume alcohol only in moderation while on thyroid therapy.

Do not stop taking Liothyronine abruptly unless directed by your doctor. Sudden discontinuation will lead to a return of hypothyroid symptoms, which can be severe. If the medication needs to be stopped due to side effects, your doctor will provide a plan to transition to another therapy or manage the withdrawal of the hormone.

> Important: Discuss all your medical conditions, especially heart disease or adrenal problems, with your healthcare provider before starting Liothyronine.

There are few absolute contraindications for drug combinations, but the following require extreme caution:

• Weight Loss Medications (Sympathomimetics): Combining Liothyronine with stimulants like phentermine or amphetamines for weight loss is strictly contraindicated due to the risk of fatal cardiac arrhythmias and severe hypertension.

• Oral Anticoagulants (e.g., Warfarin): Thyroid hormones increase the breakdown of clotting factors. This can significantly increase the blood-thinning effect of warfarin, increasing the risk of bleeding. Your doctor will need to monitor your INR (International Normalized Ratio) closely and likely reduce your warfarin dose when starting Liothyronine.
• Insulin and Oral Antidiabetics: Liothyronine can decrease the effectiveness of insulin and oral diabetes medications (like metformin or glipizide). Blood sugar levels should be monitored more frequently, and diabetes medication doses may need adjustment.
• Digitalis Glycosides (e.g., Digoxin): Thyroid hormones can decrease the effectiveness of digitalis. As thyroid status changes from hypothyroid to euthyroid, the dose of digoxin may need to be increased to maintain its effect on the heart.

• Bile Acid Sequestrants (e.g., Cholestyramine, Colestipol): These drugs bind to Liothyronine in the gut and prevent its absorption. Liothyronine should be taken at least 4 hours apart from these medications.
• Antacids and Calcium Supplements: Aluminum-containing antacids, calcium carbonate, and iron supplements can interfere with the absorption of thyroid hormones. Space these at least 4 hours away from your Liothyronine dose.
• Estrogens and Oral Contraceptives: Estrogens increase the level of thyroid-binding globulin (TBG) in the blood. This may decrease the amount of "free" (active) T3 available, potentially requiring an increase in the Liothyronine dose.
• Tricyclic Antidepressants: Use with thyroid hormones may increase the activity of both drugs, potentially leading to heart rhythm issues or increased toxicity.

• Soy and Fiber: High-fiber diets or large amounts of soy can slightly decrease the absorption of thyroid hormones. While this is more significant for levothyroxine (T4), maintaining a consistent diet is important for stable T3 levels.
• Grapefruit Juice: Unlike many other drugs, grapefruit juice does not have a major known effect on Liothyronine metabolism, but consistency in intake is always advised.

• Kelp and Iodine Supplements: Since iodine is a component of thyroid hormone, taking extra iodine can interfere with thyroid function and the effectiveness of Liothyronine. Avoid high-dose iodine supplements unless directed by a doctor.
• St. John's Wort: May potentially alter the metabolism of various drugs, though its specific effect on Liothyronine is not well-documented. Monitor for changes in symptoms.

• Biotin (Vitamin B7): High doses of biotin (found in hair/skin/nail supplements) can interfere with thyroid lab tests, often causing falsely high T3 levels and falsely low TSH levels. Stop taking biotin at least 2 days before having thyroid blood work done.

For each interaction, the primary management strategy is frequent monitoring of TSH and T3 levels and adjusting the Liothyronine dose as necessary to maintain a euthyroid state.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, as many common items can interfere with thyroid hormone levels.

Liothyronine must NEVER be used in the following circumstances:

• Untreated Thyrotoxicosis: If a patient already has an overactive thyroid (hyperthyroidism), adding synthetic T3 will dangerously exacerbate the condition, potentially leading to a thyroid storm (a life-threatening medical emergency).
• Acute Myocardial Infarction (Heart Attack): Liothyronine increases the oxygen demand of the heart. Administering it during or immediately after a heart attack can worsen cardiac damage or trigger fatal arrhythmias.
• Uncorrected Adrenal Insufficiency: Thyroid hormones increase the metabolic clearance of glucocorticoids. In patients with adrenal insufficiency, starting Liothyronine without first providing corticosteroid replacement can trigger an acute adrenal crisis (symptoms include severe low blood pressure, shock, and death).
• Hypersensitivity: A known allergy to Liothyronine sodium or any of the inactive ingredients (such as corn starch or lactose) in the tablet formulation.

These conditions require a careful risk-benefit analysis and very close medical supervision:

• Severe Coronary Artery Disease: The risk of precipitating angina or a heart attack may outweigh the benefits of rapid T3 replacement. In these patients, levothyroxine (T4) is often preferred due to its slower onset.
• Marked Hypertension: Because T3 can increase blood pressure and heart rate, it may complicate the management of severe high blood pressure.
• Elderly Patients with Cardiac Comorbidities: The high potency and rapid action of T3 make it difficult to manage safely in frail elderly patients with multiple heart issues.

There is no known cross-sensitivity between Liothyronine and unrelated drug classes. However, patients who have had a reaction to one brand of thyroid hormone should be cautious when switching to another, as the inactive fillers and dyes may differ.

> Important: Your healthcare provider will evaluate your complete medical history, especially your heart and adrenal health, before prescribing Liothyronine to ensure it is safe for you.

• FDA Pregnancy Category A: Thyroid hormones do not readily cross the placental barrier. Clinical experience has shown that Liothyronine is safe for use during pregnancy when used to maintain normal thyroid levels.
• Importance of Treatment: Untreated hypothyroidism during pregnancy is associated with a higher risk of miscarriage, preeclampsia, and impaired neurological development in the fetus.
• Monitoring: Thyroid requirements often increase during pregnancy. TSH levels should be monitored every 4-6 weeks during the first half of pregnancy and at least once in the third trimester.
• T4 vs T3: Levothyroxine (T4) is generally the preferred treatment during pregnancy because T4 is the primary hormone that crosses the placenta to support fetal brain development. Liothyronine is usually only used if the mother cannot tolerate T4 or in specific combination therapies.

• Passage into Milk: Small amounts of thyroid hormones are excreted into breast milk. However, these amounts are generally insufficient to affect the nursing infant or interfere with infant thyroid screening.
• Safety: Liothyronine is considered compatible with breastfeeding. No special precautions are typically required, but mothers should continue their prescribed dose to remain euthyroid, which supports healthy lactation.

• Growth and Development: Thyroid hormone is essential for bone maturation and brain development. Inadequate treatment can lead to permanent cognitive impairment and short stature.
• Monitoring: Children require more frequent monitoring of TSH and T3 levels, as well as regular assessments of height and weight to ensure normal growth.
• Side Effects: Children may be more prone to temporary hair loss and a rare condition called pseudotumor cerebri (increased brain pressure).

• Cardiac Sensitivity: Patients over 65 are at a much higher risk for T3-induced cardiac issues, including atrial fibrillation and angina.
• Dosing: The rule for the elderly is "Start Low and Go Slow." Doses often start at 5 mcg and are increased very gradually.
• Polypharmacy: Elderly patients are more likely to be taking other medications (like beta-blockers or blood thinners) that interact with Liothyronine.

• Adjustments: No specific dose adjustments are required for patients with kidney disease. However, since thyroid status affects kidney function (GFR), patients with chronic kidney disease should have their thyroid levels monitored closely as their renal function changes.

• Metabolism: In patients with severe liver cirrhosis, the production of thyroid-binding proteins may be decreased, and the metabolism of the hormone may be slowed. This can lead to higher levels of "free" (active) T3, requiring a lower dose of Liothyronine.

> Important: Special populations require individualized medical assessment. Never share your medication with others, especially children or the elderly.

Liothyronine (L-triiodothyronine) is the synthetic form of the most metabolically active thyroid hormone. Its primary mechanism involves entering the cell nucleus and binding to thyroid hormone receptors (TR-alpha and TR-beta). These receptors act as ligand-activated transcription factors. When Liothyronine binds, it causes the receptor to release co-repressors and recruit co-activators, which then initiates the transcription of messenger RNA (mRNA). This mRNA is translated into proteins that increase mitochondrial activity, stimulate the sodium-potassium ATPase pump, and enhance the expression of genes involved in energy production and metabolic rate.

Liothyronine has a rapid onset of action, with metabolic effects often beginning within a few hours of administration. Its duration of action is shorter than that of levothyroxine, lasting approximately 48 to 72 hours after the last dose. It does not require conversion by deiodinase enzymes, making its effect more direct and predictable in patients who may have impaired T4-to-T3 conversion. There is no evidence of tolerance development; the body's requirement for the hormone remains relatively stable unless the underlying disease state changes.

| Parameter | Value |

|---|---|

| Bioavailability | ~95% |

| Protein Binding | >99% (primarily TBG and Albumin) |

| Half-life | 1 - 2 days (shorter in hyperthyroidism) |

| Tmax | 2 - 3 hours |

| Metabolism | Hepatic deiodination; non-CYP mediated |

| Excretion | Renal (primary), Fecal (secondary) |

• Molecular Formula: C15H11I3NNaO4
• Molecular Weight: 672.96 g/mol
• Solubility: Slightly soluble in water; soluble in alkaline solutions.
• Structure: It is the sodium salt of the L-isomer of 3,3',5-triiodothyronine. It contains three iodine atoms per molecule, which are critical for its biological activity.

Liothyronine is classified as a synthetic thyroid hormone. Within the therapeutic area of endocrinology, it is categorized as an l-Triiodothyronine [EPC]. It is related to levothyroxine (T4) and desiccated thyroid extract (which contains both T3 and T4), but it is unique in providing only the pure, active T3 hormone.